Application Nr Approved Date Route Status External Links
NDA209899 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zeposia Is Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults. Zeposia Is A Sphingosine 1-Phosphate Receptor Modulator Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ozanimod Hydrochloride

Comments